Company Analysis Rossari Biotech Limited
1. Summary
Advantages
- The company's current efficiency (ROE=13.32%) is higher than the sector average (ROE=9.92%)
Disadvantages
- Price (615.7 βΉ) is higher than fair price (306.29 βΉ)
- Dividends (0.0542%) are below the sector average (1.06%).
- The stock's return over the last year (-13.11%) is lower than the sector average (3%).
- Current debt level 7.56% has increased over 5 years from 1.81%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Rossari Biotech Limited | Materials | Index | |
|---|---|---|---|
| 7 days | -7.3% | -1.3% | 3.6% |
| 90 days | -25.5% | -14.7% | -0.6% |
| 1 year | -13.1% | 3% | 7.1% |
ROSSARI vs Sector: Rossari Biotech Limited has significantly underperformed the "Materials" sector by -16.11% over the past year.
ROSSARI vs Market: Rossari Biotech Limited has significantly underperformed the market by -20.23% over the past year.
Stable price: ROSSARI is not significantly more volatile than the rest of the market on "National Stock Exchange Of India" over the last 3 months, with typical variations of +/- 5% per week.
Long period: ROSSARI with weekly volatility of -0.2521% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (615.7 βΉ) is higher than the fair price (306.29 βΉ).
Price is higher than fair: The current price (615.7 βΉ) is 50.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (28.64) is lower than that of the sector as a whole (44.36).
P/E vs Market: The company's P/E (28.64) is lower than that of the market as a whole (64.71).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (3.57) is lower than that of the sector as a whole (4.28).
P/BV vs Market: The company's P/BV (3.57) is lower than that of the market as a whole (6.37).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.04) is lower than that of the sector as a whole (3.22).
P/S vs Market: The company's P/S indicator (2.04) is lower than that of the market as a whole (18.8).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (14.92) is higher than that of the sector as a whole (-43.17).
EV/Ebitda vs Market: The company's EV/Ebitda (14.92) is lower than that of the market as a whole (34.47).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 20.06% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (20.06%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-19.27%).
5.4. ROE
ROE vs Sector: The company's ROE (13.32%) is higher than that of the sector as a whole (9.92%).
ROE vs Market: The company's ROE (13.32%) is higher than that of the market as a whole (3.59%).
5.5. ROA
ROA vs Sector: The company's ROA (8.89%) is higher than that of the sector as a whole (7.18%).
ROA vs Market: The company's ROA (8.89%) is higher than that of the market as a whole (7.91%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (11.12%) is lower than that of the sector as a whole (15.1%).
ROIC vs Market: The company's ROIC (11.12%) is lower than that of the market as a whole (15.54%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0.0542% is below the average for the sector '1.06%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0.0542% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 0.0542% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (2.11%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
